| Stage | SBAC | % of rev | RAL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $715M | 100.00% | $568M | 100.00% | SBAC ×1.26 |
| Gross profit | $539M | 75.39% | $293M | 51.59% | SBAC +23.8pp |
| Operating income | $352M | 49.19% | $82M | 14.48% | SBAC +34.7pp |
| Pre-tax income | $232M | 32.50% | $69M | 12.06% | SBAC +20.4pp |
| Net income | $196M | 27.47% | $57M | 10.07% | SBAC +17.4pp |
| Stage | SBAC | RAL | Gap · A − B |
|---|---|---|---|
| Revenue | $715M100.00% | $568M100.00% | SBAC ×1.26 |
| Gross profit | 75.39%$539M | 51.59%$293M | SBAC +23.8pp |
| Operating income | 49.19%$352M | 14.48%$82M | SBAC +34.7pp |
| Pre-tax income | 32.50%$232M | 12.06%$69M | SBAC +20.4pp |
| Net income |
| 27.47%$196M |
| 10.07%$57M |
| SBAC +17.4pp |
No shared counterparties.